Entera Bio Ltd. Ordinary Shares (ENTX) Stock Price, Quote & AI Analysis
Live ENTX stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Entera Bio Ltd. Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Entera Bio Ltd. Ordinary Shares (ENTX), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Entera Bio Ltd. Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Entera Bio Ltd. Ordinary Shares Overview
Company information
Company Overview
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Entera Bio Ltd. Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...